150 results on '"Uzuka, Takeo"'
Search Results
2. Rise of oligodendroglioma hypermutator phenotype from a subclone harboring TP53 mutation after TMZ treatment
3. Gene expression profiling of 19q-loss astrocytomas suggest a specific pattern associated with the better prognosis
4. Successful treatment of non-HIV progressive multifocal leukoencephalopathy: case report and literature review
5. 10100-MNG-4 RISK FACTORS FOR POSTOPRATIVE RECURRENCE IN PATIENTS WITH CONVEXITY, PARASAGITTAL AND FALX MENINGIOMAS
6. Histology of hemangioblastoma treated with stereotactic radiosurgery confirms its effectiveness
7. High Incidence of Deep Vein Thrombosis in the Perioperative Period of Neurosurgical Patients
8. Development of a rapid and comprehensive genomic profiling test supporting diagnosis and research for brain tumors
9. Rise of oligodendroglioma hypermutator phenotype from a subclone harboring TP53 mutation after TMZ treatment
10. Clinical outcomes of brain metastases from hepatocellular carcinoma: a multicenter retrospective study and a literature review
11. Bevacizumab beyond Progression for Newly Diagnosed Glioblastoma (BIOMARK): Phase II Safety, Efficacy and Biomarker Study
12. PATH-23. HIGHLY INFILTRATING OLIGODENDROGLIOMAS SHOW DIFFERENT MORPHOLOGY FROM TYPICAL OLIGODENDROGLIOMAS WHILE MAINTAINING GOOD RESPONSE TO CHEMO-RADIATION THERAPY
13. Classification of adult diffuse gliomas by molecular markers—a short review with historical footnote
14. Treatment outcomes in glioblastoma patients aged 76 years or older: a multicenter retrospective cohort study
15. RADT-23. RECURRENT OLIGODENDROGLIOMAS AFTER FIRST CHEMO-RADIATION THERAPY RESPONDED REMARKABLY TO RE-RADIATION
16. Indication of intraoperative immunohistochemistry for accurate pathological diagnosis of brain tumors
17. Basal ganglion hamartoma in a patient presenting with precocious puberty
18. Induction of autophagy in temozolomide treated malignant gliomas
19. Anaplastic astrocytoma with angiocentric ependymal differentiation
20. QOLP-07. HEALTH-RELATED QUALITY OF LIFE AND SYMPTOM BURDEN IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA TREATED WITH BEVACIZUMAB BEYOND PROGRESSION: A PROSPECTIVE TRIAL
21. PATH-08. EVALUATION OF MISMATCH REPAIR GENE EXPRESSION BY IMMUNOHISTOCHEMISTRY MAY DETECT EARLY PHASE OF MMR DEFICIENCY IN RECURRENT GLIOMAS
22. PATH-10. EFFECTS OF 19q-LOSS IN IDH-MUTATED ASTROCYTOMAS ON BETTER PROGNOSIS AND OLIGODENDROGLIOMA-LIKE MORPHOLOGY
23. MPC-11 Comprehensive gene expression analysis of IDH-mutated astrocytomas with 19q-loss
24. So-called bifocal tumors with diabetes insipidus and negative tumor markers: are they all germinoma?
25. Intraventricular pleomorphic xanthoastrocytoma with anaplastic features
26. 10070: MET-02 NON-SMALL-CELL LUNG CANCER WITH SYNCHRONOUS BRAIN METASTASIS IN THE ERA OF MOLECULAR TARGETED DRUGS: TREATMENT OUTCOME AND RISK FACTORS
27. MPC-07 MECHANISMS OF BETTER PROGNOSIS IN IDH-MUTATED ASTROCYTOMA WITH 19Q-LOSS
28. Successful treatment of non-HIV progressive multifocal leukoencephalopathy: case report and literature review
29. ACTR-04. BIOMARK: A PHASE II STUDY OF BEVACIZUMAB BEYOND PROGRESSION FOR NEWLY DIAGNOSED GLIOBLASTOMA: SAFETY, EFFICACY AND PROSPECTIVE BIOMARKER ANALYSIS
30. Brain invasion by chronic lymphocytic leukemia
31. IDH‐mutated astrocytomas with 19q‐loss constitute a subgroup that confers better prognosis
32. Intravascular Lymphoma with an Acute Course of Cerebellar Hemorrhage: A Case Report
33. Additional file 3: Figure S1. of A combination of TERT promoter mutation and MGMT methylation status predicts clinically relevant subgroups of newly diagnosed glioblastomas
34. PATH-21. IDH-MUTATED, 19q DELETED, TP53 MUTATED ANAPLASTIC GLIOMAS CONSTITUTE A SUBGROUP THAT LOOK LIKE AND BEHAVE LIKE ANAPLASTIC OLIGODENDROGLIOMAS
35. Surgical Site Infection after Malignant Brain Tumor Resection: A Multicenter Study for Induction of a Basic Care Bundle
36. MNGO-06. CLINICAL COURSE OF GRADE II MENINGIOMAS INDICATE POSSIBILITY OF OVER DIAGNOSIS
37. Classification of adult diffuse gliomas by molecular markers—a short review with historical footnote
38. A combination of TERT promoter mutation and MGMT methylation status predicts clinically relevant subgroups of newly diagnosed glioblastomas
39. Brain invasion by chronic lymphocytic leukemia.
40. Near-infrared spectroscopic study and the Wada test for presurgical evaluation of expressive and receptive language functions in glioma patients: With a case report of dissociated language functions
41. ATCT-23MULTICENTER RETROSPECTIVE STUDY TO COMPARE CHEMORADIOTHERAPY WITH TEMOZOLOMIDE OR ACNU IN 535 ANAPLASTIC GLIOMAS
42. Development of Coaxial Needle Applicator Made of Shape Memory Alloy
43. A New Heating Control Method for Effective Hyperthermia Treatment of a Brain Tumor Using the Resonant Cavity Applicator with a Segmented Dielectric Bolus
44. Heating properties of the resonant cavity applicator with ultrasound monitoring system for effective hyperthermia treatments.
45. Effectiveness of Maximal Safe Resection for Glioblastoma Including Elderly and Low Karnofsky Performance Status Patients: Retrospective Review at a Single Institute
46. A Support System in Virtual Reality for Effective Hyperthermia Treatments : Heating Properties of Needle Applicator for Brain Tumors
47. Fiber Tract Visualization and Intraoperative Functional Neuronavigation(Operation Suite in 21st Century)
48. Anaplastic astrocytoma with angiocentric ependymal differentiation
49. Development of Automatic Impedance Matching System for Resonant Cavity Applicator
50. Intraventricular pleomorphic xanthoastrocytoma with anaplastic features
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.